11: Molecular & Biochemical Basis of Disease Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is allelic heterogeneity?

A

The occurrence of more than one allele at a locus.

Different mutations at the same locus cause similar disease phenotypes.

E.g., cystic fibrosis: 1,000+ mutations in CFTR can result in disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is locus heterogeneity?

A

The association of more than one locus with a specific clinical phenotype.

A phenotype caused by mutations in genes at different loci.

E.g., hyperphenylalanemia: caused by mutated phenylalanine hydroxylase (classic PKU) or mutation in gene for BH4 cofactor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is clinical/phenotypic heterogeneity?

A

The association of more than one phenotype with mutatins a a single locus.

Different mutations in a single gene lead to varied phenotypes.

E.g., phenylalanine hydroxylase mutation can cause PKU, variant PKU, or non-PKU hyperphenylalanemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe loss-of-function mutations.

A
  • Account for 90% of mutations
  • Results in haploinsufficiency
  • Often autosomal recessive
    • Tay Sachs
    • Cystic fibrosis
  • 50% of normal activity is sufficient (thus, carriers are unaffected)
  • Majority of inborn errors of metabiolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the characteristics of enzyme deficiencies?

A
  • Enzymopathies are almost always recessive
  • Leads to either:
    • Substrate accumulation (shunted down toxic alternative pathway)
    • Product deficiency
  • Loss of multiple enzyme activities
  • Phenotypic homology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the treatment priniciples for inborn errors of metabolism?

A
  • Dietary modification
  • Control of endogenous production of substrate
  • Vitamins and cofactors
  • Enzyme replacement
  • Transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is hyperphenylalaninemia?

A
  • Mildly or strongly elevated levels of the amino acid phenylalanine in the blood.
  • Autosomal recessive condition
  • Phenylalanine necessary for making tyrosine, dopamine, serotonin, norepinephrine; in these IEOMs, these products are not being produced.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is alpha-1 antitrypsin disorder?

A
  • Autosomal recessive condition.
  • Different mutations can cause different phenotypes (phenotypic heterogeneity).
  • Alpha-1 antitrypsin is a protease inhibitor of elastase.
    • Inhibitor not produced –> elastase breaks down elastin in lung –> destruction of alveoli –> COPD
  • Most common phenotype is chronic obstructive pulmonary disease (COPD).
  • Smoking causes more oxidative stress –> destroys residual anti-trypsin activity –> worse prognosis
  • Z/Z mutation: misfolded anti-trypsin can’t get out of hepatocytes (where they are produced) –> hepatocyte damage –> cirrhosis + COPD
  • Example of phenotypic heterogeneity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Duchenne Muscular Dystrophy?

A
  • Dystrophin anchors protein complex to cell membrane to maintain muscle membrane integrity (links actin to extracellular matrix).
  • Severity of dystrophinopathy correlates with protein production (less severe = Becker).
  • Example of phenotypic heterogeneity.
  • Most often due to gene deletion (60%; 1 exon to whole gene)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some autosomal dominant loss-of-function mutations?

A
  • Tumor suppressor genes
    • BRCA1&2
    • Retinoblastoma
    • Familial adenomatous polyposis
  • 50% of normal activity sufficient, but loss of second gene results in disease (2-hit hypothesis; recessive on cellular level)
    • Due to loss of second, somatic gene during lifetime (inherited almost as if carrier, but will develop somatic mutation during lifetime therefore considered AD).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is haploinsufficiency?

A
  • 50% of normal activity is NOT sufficient for normal activity; leads to abnormal phenotype
  • Example: Maturity onset diabetes of youth (MODY): mutation in 1 allele of glucokinase leads to loss of sensitization to glucose concentrations
    • Regulation step lost; incorrectly sensing ambient glucokinase levels; “thermostat set too high”
    • Autosomal dominant
  • Example: Acute Intermittent Porphyria
    • Autosomal dominant
    • Asymptomatic until drug is used that decreases heme concentrations (e.g., barbiturates)
  • Example: LDL Receptor Deficiency
    • 2 WT copies of LDL receptor = normal cholesterol levels
    • Obligate mutant heterozygotes = moderately high levels of cholesterol
    • Mutant homozygotes = severe levels of cholesterol; heart attacks, coronary disease by late teens
    • Example of dose-effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is ichthyosis with confetti?

A
  • AD condition where a 2nd hit of mutation reverses it (i.e., cures it): revertant spots
  • Mitotic homologous recombination
  • Loss of heterozygosity to homozygosity
  • Rescues the phenotype
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a dominant negative mutation (antimorph)?

A
  • Act in opposition to normal gene activity; acts antagonistically (poisons) normal gene product (usually from multimer formation)
  • Example: osteogenesis imperfecta
    • Autosomal dominant
    • Brittle bone disease, lots of fractures
    • Collagen composed of 2 alpha-1 strands, 1 alpha-2 strand
    • Mutation at glycine –> inability to make tight turns in triple helix of alpha-1
    • Deletion –> quantitative problems (not enough collagen): Type I OI
    • Missense –> qualitative problems (abnormal collagen); this is WORSE, because more collagen affected (75% of fibers “poisoned”): Type I, II, III or IV OI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a gain-of-function mutation?

A
  • Change to the gene product such that it gains a new and abnormal function; overly expressed or new function; dominant negative effect
  • Example 1: Huntington’s Disease
    • CAG polyglutamine repeat –> novel function of gene product –> kills neurons –> brain atrophy
    • Larger the repeat size, earlier onset of disease
    • Disease presents at earlier age as it is passed down to subsequent generation from father (anticipation) due to repeat expansion
  • Example 2: Myotonic Dystrophy
    • Expanded repeat affects binding to RNA binding proteins
    • Anticipation occurs from mother
    • Fish mouth phenotype
  • Example 3: Fragile X
    • CGG repeat on 5’ UTR
    • >200 copies leads to excessive methylation and silences transcription of FMR1 gene
    • If 6-200 repeats, **tremor/ataxia syndrome **
  • Example 4: Achondroplasia
    • Autosomal dominant
    • FGFR3 gain of function leads to severe limitation of bone growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly